China Biosimilar Drug Market Research Report 2018

Publisher Name :
Date: 15-Mar-2018
No. of pages: 98
Inquire Before Buying

The global Biosimilar Drug market is valued at XX million USD in 2017 and is expected to reach XX million USD by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

China plays an important role in global market, with market size of xx million USD in 2017 and will be xx million USD in 2025, with a CAGR of xx%.

This report studies the Biosimilar Drug development status and future trend in China, focuses on top players in China, also splits Biosimilar Drug by type and by applications, to fully and deeply research and reveal the market general situation and future forecast.

The major players in China market include

- CP Guojian Pharma

- Biotech Pharma

- Celgen Pharma

- Henlius

Geographically, this report splits the China market into six regions,

- South China

- East China

- Southwest China

- Northeast China

- North China

- Central China

- Northwest China

On the basis of product, this report displays the sales volume (K MT), revenue (Million USD), product price (USD/MT), market share and growth rate of each type, primarily split into

- Injection

- Tablets

- Others

On the basis of the end users/application, this report covers

- Ankylosing Spondylitis

- Tumor

- Rheumatoid Arthrtis

- Cardiovascular

If you have any special requirements, please let us know and we will offer you the report as you want.

China Biosimilar Drug Market Research Report 2018

Table of Contents
China Biosimilar Drug Market Research Report 2018
1 Biosimilar Drug Overview
1.1 Product Overview and Scope of Biosimilar Drug
1.2 Classification of Biosimilar Drug by Product Category
1.2.1 China Biosimilar Drug Sales (K MT) Comparison by Type (2013-2025)
1.2.2 China Biosimilar Drug Sales (K MT) Market Share by Type in 2017
1.2.3 Injection
1.2.4 Tablets
1.2.5 Others
1.3 China Biosimilar Drug Market by Application/End Users
1.3.1 China Biosimilar Drug Sales (K MT) and Market Share Comparison by Applications (2013-2025)
1.3.2 Ankylosing Spondylitis
1.3.3 Tumor
1.3.4 Rheumatoid Arthrtis
1.3.5 Cardiovascular
1.4 China Biosimilar Drug Market by Region
1.4.1 China Biosimilar Drug Market Size (Million USD) Comparison by Region (2013-2025)
1.4.2 South China Biosimilar Drug Status and Prospect (2013-2025)
1.4.3 East China Biosimilar Drug Status and Prospect (2013-2025)
1.4.4 Southwest China Biosimilar Drug Status and Prospect (2013-2025)
1.4.5 Northeast China Biosimilar Drug Status and Prospect (2013-2025)
1.4.6 North China Biosimilar Drug Status and Prospect (2013-2025)
1.4.7 Central China Biosimilar Drug Status and Prospect (2013-2025)
1.5 China Market Size (Sales and Revenue) of Biosimilar Drug (2013-2025)
1.5.1 China Biosimilar Drug Sales (K MT) and Growth Rate (%)(2013-2025)
1.5.2 China Biosimilar Drug Revenue (Million USD) and Growth Rate (%)(2013-2025)
2 China Biosimilar Drug Market Competition by Players/Manufacturers
2.1 China Biosimilar Drug Sales and Market Share of Key Players/Manufacturers (2013-2018)
2.2 China Biosimilar Drug Revenue and Share by Players/Manufacturers (2013-2018)
2.3 China Biosimilar Drug Average Price (USD/MT) by Players/Manufacturers (2013-2018)
2.4 China Biosimilar Drug Market Competitive Situation and Trends
2.4.1 China Biosimilar Drug Market Concentration Rate
2.4.2 China Biosimilar Drug Market Share of Top 3 and Top 5 Players/Manufacturers
2.4.3 Mergers & Acquisitions, Expansion in China Market
2.5 China Players/Manufacturers Biosimilar Drug Manufacturing Base Distribution, Sales Area, Product Types
3 China Biosimilar Drug Sales and Revenue by Region (2013-2018)
3.1 China Biosimilar Drug Sales (K MT) and Market Share by Region (2013-2018)
3.2 China Biosimilar Drug Revenue (Million USD) and Market Share by Region (2013-2018)
3.3 China Biosimilar Drug Price (USD/MT) by Regions (2013-2018)
4 China Biosimilar Drug Sales and Revenue by Type/ Product Category (2013-2018)
4.1 China Biosimilar Drug Sales (K MT) and Market Share by Type/ Product Category (2013-2018)
4.2 China Biosimilar Drug Revenue (Million USD) and Market Share by Type (2013-2018)
4.3 China Biosimilar Drug Price (USD/MT) by Type (2013-2018)
4.4 China Biosimilar Drug Sales Growth Rate (%) by Type (2013-2018)
5 China Biosimilar Drug Sales by Application (2013-2018)
5.1 China Biosimilar Drug Sales (K MT) and Market Share by Application (2013-2018)
5.2 China Biosimilar Drug Sales Growth Rate (%) by Application (2013-2018)
5.3 Market Drivers and Opportunities
6 China Biosimilar Drug Players/Suppliers Profiles and Sales Data
6.1 CP Guojian Pharma
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Biosimilar Drug Product Category, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 CP Guojian Pharma Biosimilar Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (%)(2013-2018)
6.1.4 Main Business/Business Overview
6.2 Biotech Pharma
6.2.1 Company Basic Information, Manufacturing Base and Competitors
6.2.2 Biosimilar Drug Product Category, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 Biotech Pharma Biosimilar Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (%)(2013-2018)
6.2.4 Main Business/Business Overview
6.3 Celgen Pharma
6.3.1 Company Basic Information, Manufacturing Base and Competitors
6.3.2 Biosimilar Drug Product Category, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 Celgen Pharma Biosimilar Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (%)(2013-2018)
6.3.4 Main Business/Business Overview
6.4 Henlius
6.4.1 Company Basic Information, Manufacturing Base and Competitors
6.4.2 Biosimilar Drug Product Category, Application and Specification
6.4.2.1 Product A
6.4.2.2 Product B
6.4.3 Henlius Biosimilar Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (%)(2013-2018)
6.4.4 Main Business/Business Overview
7 Biosimilar Drug Manufacturing Cost Analysis
7.1 Biosimilar Drug Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Biosimilar Drug
8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Biosimilar Drug Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Biosimilar Drug Major Manufacturers in 2017
8.4 Downstream Buyers
9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List
10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change
11 China Biosimilar Drug Market Size (Sales and Revenue) Forecast (2018-2025)
11.1 China Biosimilar Drug Sales (K MT), Revenue (Million USD) Forecast (2018-2025)
11.2 China Biosimilar Drug Sales (K MT) Forecast by Type (2018-2025)
11.3 China Biosimilar Drug Sales (K MT) Forecast by Application (2018-2025)
11.4 China Biosimilar Drug Sales (K MT) Forecast by Region (2018-2025)
12 Research Findings and Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
List of Tables and Figures
Figure Global and China Market Size (Million USD) Comparison (2013-2025)
Table Biosimilar Drug Sales (K MT) and Revenue (Million USD) Market Split by Product Type
Table Biosimilar Drug Sales (K MT) by Application (2013-2025)
Figure Product Picture of Biosimilar Drug
Table China Biosimilar Drug Sales (K MT) and Growth Rate (%) Comparison by Types (Product Category) (2013-2025)
Figure China Biosimilar Drug Sales Volume Market Share by Types in 2017
Figure Injection Product Picture
Figure Tablets Product Picture
Figure Others Product Picture
Figure China Biosimilar Drug Sales (K MT) Comparison by Application (2013-2025)
Figure China Sales Market Share (%) of Biosimilar Drug by Application in 2017
Figure Ankylosing Spondylitis Examples
Table Key Downstream Customer in Ankylosing Spondylitis
Figure Tumor Examples
Table Key Downstream Customer in Tumor
Figure Rheumatoid Arthrtis Examples
Table Key Downstream Customer in Rheumatoid Arthrtis
Figure Cardiovascular Examples
Table Key Downstream Customer in Cardiovascular
Figure South China Biosimilar Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure East China Biosimilar Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southwest China Biosimilar Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure Northeast China Biosimilar Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure North China Biosimilar Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure Central China Biosimilar Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure China Biosimilar Drug Sales (K MT) and Growth Rate (%)(2013-2025)
Figure China Biosimilar Drug Revenue (Million USD) and Growth Rate (%)(2013-2025)
Table China Biosimilar Drug Sales of Key Players/Manufacturers (2013-2018)
Table China Biosimilar Drug Sales Share (%) by Players/Manufacturers (2013-2018)
Figure 2017 China Biosimilar Drug Sales Share (%) by Players/Manufacturers
Figure 2017 China Biosimilar Drug Sales Share (%) by Players/Manufacturers
Table China Biosimilar Drug Revenue by Players/Manufacturers (2013-2018)
Table China Biosimilar Drug Revenue Market Share (%) by Players/Manufacturers (2013-2018)
Figure 2017 China Biosimilar Drug Revenue Market Share (%) by Players/Manufacturers
Figure 2017 China Biosimilar Drug Revenue Market Share (%) by Players/Manufacturers
Table China Market Biosimilar Drug Average Price of Key Players/Manufacturers (2013-2018)
Figure China Market Biosimilar Drug Average Price of Key Players/Manufacturers in 2017
Figure China Biosimilar Drug Market Share of Top 3 Players/Manufacturers
Figure China Biosimilar Drug Market Share of Top 5 Players/Manufacturers
Table China Players/Manufacturers Biosimilar Drug Manufacturing Base Distribution and Sales Area
Table China Players/Manufacturers Biosimilar Drug Product Category
Table China Biosimilar Drug Sales (K MT) by Regions (2013-2018)
Table China Biosimilar Drug Sales Share (%) by Regions (2013-2018)
Figure China Biosimilar Drug Sales Share (%) by Regions (2013-2018)
Figure China Biosimilar Drug Sales Market Share (%) by Regions in 2017
Table China Biosimilar Drug Revenue (Million USD) and Market Share by Regions (2013-2018)
Table China Biosimilar Drug Revenue Market Share (%) by Regions (2013-2018)
Figure China Biosimilar Drug Revenue Market Share (%) by Regions (2013-2018)
Figure China Biosimilar Drug Revenue Market Share (%) by Regions in 2017
Table China Biosimilar Drug Price (USD/MT) by Regions (2013-2018)
Table China Biosimilar Drug Sales (K MT) by Type (2013-2018)
Table China Biosimilar Drug Sales Share (%) by Type (2013-2018)
Figure China Biosimilar Drug Sales Share (%) by Type (2013-2018)
Figure China Biosimilar Drug Sales Market Share (%) by Type in 2017
Table China Biosimilar Drug Revenue (Million USD) and Market Share by Type (2013-2018)
Table China Biosimilar Drug Revenue Market Share (%) by Type (2013-2018)
Figure Revenue Market Share of Biosimilar Drug by Type (2013-2018)
Figure Revenue Market Share of Biosimilar Drug by Type in 2017
Table China Biosimilar Drug Price (USD/MT) by Types (2013-2018)
Figure China Biosimilar Drug Sales Growth Rate (%) by Type (2013-2018)
Table China Biosimilar Drug Sales (K MT) by Applications (2013-2018)
Table China Biosimilar Drug Sales Market Share (%) by Applications (2013-2018)
Figure China Biosimilar Drug Sales Market Share (%) by Application (2013-2018)
Figure China Biosimilar Drug Sales Market Share (%) by Application in 2017
Table China Biosimilar Drug Sales Growth Rate (%) by Application (2013-2018)
Figure China Biosimilar Drug Sales Growth Rate (%) by Application (2013-2018)
Table CP Guojian Pharma Biosimilar Drug Basic Information List
Table CP Guojian Pharma Biosimilar Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (%)(2013-2018)
Figure CP Guojian Pharma Biosimilar Drug Sales (K MT) and Growth Rate (%)(2013-2018)
Figure CP Guojian Pharma Biosimilar Drug Sales Market Share (%) in China (2013-2018)
Figure CP Guojian Pharma Biosimilar Drug Revenue Market Share (%) in China (2013-2018)
Table Biotech Pharma Biosimilar Drug Basic Information List
Table Biotech Pharma Biosimilar Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (%)(2013-2018)
Figure Biotech Pharma Biosimilar Drug Sales (K MT) and Growth Rate (%)(2013-2018)
Figure Biotech Pharma Biosimilar Drug Sales Market Share (%) in China (2013-2018)
Figure Biotech Pharma Biosimilar Drug Revenue Market Share (%) in China (2013-2018)
Table Celgen Pharma Biosimilar Drug Basic Information List
Table Celgen Pharma Biosimilar Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (%)(2013-2018)
Figure Celgen Pharma Biosimilar Drug Sales (K MT) and Growth Rate (%)(2013-2018)
Figure Celgen Pharma Biosimilar Drug Sales Market Share (%) in China (2013-2018)
Figure Celgen Pharma Biosimilar Drug Revenue Market Share (%) in China (2013-2018)
Table Henlius Biosimilar Drug Basic Information List
Table Henlius Biosimilar Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (%)(2013-2018)
Figure Henlius Biosimilar Drug Sales (K MT) and Growth Rate (%)(2013-2018)
Figure Henlius Biosimilar Drug Sales Market Share (%) in China (2013-2018)
Figure Henlius Biosimilar Drug Revenue Market Share (%) in China (2013-2018)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Biosimilar Drug
Figure Manufacturing Process Analysis of Biosimilar Drug
Figure Biosimilar Drug Industrial Chain Analysis
Table Raw Materials Sources of Biosimilar Drug Major Players/Manufacturers in 2017
Table Major Buyers of Biosimilar Drug
Table Distributors/Traders List
Figure China Biosimilar Drug Sales (K MT) and Growth Rate (%) Forecast (2018-2025)
Figure China Biosimilar Drug Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure China Biosimilar Drug Price (USD/MT) Trend Forecast (2018-2025)
Table China Biosimilar Drug Sales (K MT) Forecast by Type (2018-2025)
Figure China Biosimilar Drug Sales (K MT) Forecast by Type (2018-2025)
Figure China Biosimilar Drug Sales Volume Market Share Forecast by Type in 2025
Table China Biosimilar Drug Sales (K MT) Forecast by Application (2018-2025)
Figure China Biosimilar Drug Sales Volume Market Share Forecast by Application (2018-2025)
Figure China Biosimilar Drug Sales Volume Market Share Forecast by Application in 2025
Table China Biosimilar Drug Sales (K MT) Forecast by Regions (2018-2025)
Table China Biosimilar Drug Sales Volume Share Forecast by Regions (2018-2025)
Figure China Biosimilar Drug Sales Volume Share Forecast by Regions (2018-2025)
Figure China Biosimilar Drug Sales Volume Share Forecast by Regions in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
  • Global and Chinese Adalimumab Biosimilar Industry, 2018 Market Research Report
    Published: 08-Dec-2018        Price: US 3000 Onwards        Pages: 139
    The 'Global and Chinese Adalimumab Biosimilar Industry, 2013-2023 Market Research Report' is a professional and in-depth study on the current state of the global Adalimumab Biosimilar industry with a focus on the Chinese market. The report provides key statistics on the market status of the Adalimumab Biosimilar manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry. Firstly, the report provides a basic overview of the industry i......
  • Global Oncology Biosimilars Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 06-Dec-2018        Price: US 3480 Onwards        Pages: 132
    Oncology biosimilars are similar versions of oncology biologics that are manufactured by different companies and have been officially approved for cancer treatment. Biosimilars are cost-effective molecules with the same efficacy and potency as the original reference biologic. The relatively easy manufacturing of biosimilars and the license to manufacture biosimilars after the expiration of original reference biologic is acting in favor of the global oncology biosimilars market. Sc......
  • Global Adalimumab Biosimilar Market Research Report 2012-2023
    Published: 05-Dec-2018        Price: US 3290 Onwards        Pages: 106
    Summary The global Adalimumab Biosimilar market will reach xxx Million USD in 2017 with CAGR xx% 2018-2023. The objective of report is to define, segment, and project the market on the basis of product type, application, and region, and to describe the content about the factors influencing market dynamics, policy, economic, technology and market entry etc. Based on products type, the report describes major products type share of regional market. Products mentioned a......
  • Global and Chinese Biosimilar Drug Industry, 2018 Market Research Report
    Published: 02-Dec-2018        Price: US 3000 Onwards        Pages: 139
    The 'Global and Chinese Biosimilar Drug Industry, 2013-2023 Market Research Report' is a professional and in-depth study on the current state of the global Biosimilar Drug industry with a focus on the Chinese market. The report provides key statistics on the market status of the Biosimilar Drug manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry. Firstly, the report provides a basic overview of the industry including its defin......
  • Global and Chinese Biosimilar Monoclonal Antibodies Industry, 2018 Market Research Report
    Published: 23-Nov-2018        Price: US 3000 Onwards        Pages: 149
    The 'Global and Chinese Biosimilar Monoclonal Antibodies Industry, 2013-2023 Market Research Report' is a professional and in-depth study on the current state of the global Biosimilar Monoclonal Antibodies industry with a focus on the Chinese market. The report provides key statistics on the market status of the Biosimilar Monoclonal Antibodies manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry. Firstly, the report provides a......
  • Global Biologics and Biosimilars Market Research Report 2018
    Published: 09-Nov-2018        Price: US 2900 Onwards        Pages: 126
    This report studies the global Biologics and Biosimilars market status and forecast, categorizes the global Biologics and Biosimilars market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, and other regions (India, Southeast Asia). The major manufacturers covered in this report - Pfizer - Roche - Amgen - AbbVie - Sanofi......
  • Global Oncology Biosimilars Market Research Report 2018
    Published: 05-Nov-2018        Price: US 2900 Onwards        Pages: 119
    This report studies the global Oncology Biosimilars market status and forecast, categorizes the global Oncology Biosimilars market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, and other regions (India, Southeast Asia). The major manufacturers covered in this report - Celltrion Inc. - Pfizer Inc. - Biocon - BIOCAD - Apote......
  • Global Adalimumab Biosimilar Market Insights, Forecast to 2025
    Published: 05-Nov-2018        Price: US 3900 Onwards        Pages: 119
    This report studies the global market size of Adalimumab Biosimilar in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Adalimumab Biosimilar in these regions. This research report categorizes the global Adalimumab Biosimilar market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future trends, market dri......
  • Global Biosimilar Drug Market Insights, Forecast to 2025
    Published: 31-Oct-2018        Price: US 3900 Onwards        Pages: 112
    This report studies the global market size of Biosimilar Drug in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Biosimilar Drug in these regions. This research report categorizes the global Biosimilar Drug market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunitie......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs